4-[3-amino-2-[hydroxy-(2-methoxyethyl)-methyl-λ4-sulfanyl]-4-phenylthieno[2,3-b]pyridin-6-yl]-1H-pyrimidin-6-one
C21H22N4O3S2 — CID 162728453
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[3-amino-2-[hydroxy-(2-methoxyethyl)-methyl-λ4-sulfanyl]-4-phenylthieno[2,3-b]pyridin-6-yl]-1H-pyrimidin-6-one
4-[3-amino-2-[hydroxy-(2-methoxyethyl)-methyl-λ4-sulfanyl]-4-phenylthieno[2,3-b]pyridin-6-yl]-1H-pyrimidin-6-one (PubChem CID 162728453) has the molecular formula C21H22N4O3S2 and a molecular weight of 442.57 g/mol. Its IUPAC name is 4-[3-amino-2-[hydroxy-(2-methoxyethyl)-methyl-λ4-sulfanyl]-4-phenylthieno[2,3-b]pyridin-6-yl]-1H-pyrimidin-6-one.
Molecular Properties
| Compound Name | 4-[3-amino-2-[hydroxy-(2-methoxyethyl)-methyl-λ4-sulfanyl]-4-phenylthieno[2,3-b]pyridin-6-yl]-1H-pyrimidin-6-one |
|---|---|
| PubChem CID | 162728453 |
| Molecular Formula | C21H22N4O3S2 |
| Molecular Weight | 442.57 g/mol |
| Exact Mass | 442.11 |
| IUPAC Name | 4-[3-amino-2-[hydroxy-(2-methoxyethyl)-methyl-λ4-sulfanyl]-4-phenylthieno[2,3-b]pyridin-6-yl]-1H-pyrimidin-6-one |
| SMILES | COCCS(C)(O)c1sc2nc(-c3cc(=O)[nH]cn3)cc(-c3ccccc3)c2c1N |
| InChI | InChI=1S/C21H22N4O3S2/c1-28-8-9-30(2,27)21-19(22)18-14(13-6-4-3-5-7-13)10-16(25-20(18)29-21)15-11-17(26)24-12-23-15/h3-7,10-12,27H,8-9,22H2,1-2H3,(H,23,24,26) |
| InChIKey | NVHZTXFIVFFWSK-UHFFFAOYSA-N |
| XLogP | 4.21 |
| TPSA | 114.12 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 442.57 |
| LogP ≤ 5 | 4.21 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162728453 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.